I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fury, Matthew G.
162
results:
Online X
Search for persons
X
Format
Online (162)
Mediatypes
Articles (Online) (127)
Bookchapter (Online) (4)
OpenAccess-fulltext (31)
Sorted by: Relevance
Sorted by: Year
?
1
Quality of life in cemiplimab-treated patients with locally..:
Stratigos, Alexander J
;
Chen, Chieh-I
;
Ivanescu, Cristina
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
2
PP01.85 A Phase 2/3 Study of Fianlimab, Cemiplimab, plus Ch..:
Gabrail, Nashat
;
Faulkner, Neil
;
Nair, Santosh
...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e39 , 2024
Link:
https://doi.org/10.1016/..
?
3
Health-Related Quality of Life in Patients with Metastatic ..:
Lewis, Karl D
;
Inocencio, Timothy J
;
Quek, Ruben GW
...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s337 , 2024
Link:
https://doi.org/10.25251..
?
4
High response rate with extended dosing of cemiplimab in ad..:
Rischin, Danny
;
Hughes, Brett G M
;
Basset-Séguin, Nicole
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 3 - p. e008325 , 2024
Link:
https://doi.org/10.1136/..
?
5
Health‐related quality of life in patients with metastatic ..:
Peris, Ketty
;
Inocencio, Timothy J.
;
Stratigos, Alexander J.
...
Cancer Medicine. 13 (2024) 14 - p. , 2024
Link:
https://doi.org/10.1002/..
?
6
PP01.87 A Phase 2/3 Study of Fianlimab plus Cemiplimab vers..:
Faulkner, Neil
;
Nair, Santosh
;
Gabrail, Nashat
...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e39 , 2024
Link:
https://doi.org/10.1016/..
?
7
Phase 2 study of cemiplimab in patients with locally advanc..:
Stratigos, Alexander J
;
Sekulic, Aleksandar
;
Peris, Ketty
...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s178 , 2023
Link:
https://doi.org/10.25251..
?
8
Primary analysis of Phase 2 results for cemiplimab in patie..:
Lewis, Karl D
;
Peris, Ketty
;
Sekulic, Aleksandar
...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s177 , 2023
Link:
https://doi.org/10.25251..
?
9
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneou..:
Gross, Neil D
;
Miller, David M
;
Khushalani, Nikhil I
...
The Lancet Oncology. 24 (2023) 11 - p. 1196-1205 , 2023
Link:
https://doi.org/10.1016/..
?
10
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemothera..:
Oaknin, Ana
;
Monk, Bradley J.
;
Vergote, Ignace
...
European Journal of Cancer. 174 (2022) - p. 299-309 , 2022
Link:
https://doi.org/10.1016/..
?
11
Real-World Treatment Patterns and Outcomes Among Patients w..:
Cowey, Lance
;
Chen, Chieh-I.
;
Aguilar, Kathleen M.
...
Dermatology and Therapy. 12 (2022) 5 - p. 1211-1224 , 2022
Link:
https://doi.org/10.1007/..
?
12
Hedgehog pathway inhibitor real-world treatment patterns in..:
Ge, Wenzhen
;
Chen, Chieh-I
;
Wu, Ning
...
Future Oncology. 18 (2022) 23 - p. 2561-2572 , 2022
Link:
https://doi.org/10.2217/..
?
13
Pharmacodynamic and therapeutic pilot studies of single-age..:
Burman, Bharat
;
Drutman, Scott B.
;
Fury, Matthew G.
...
Oral Oncology. 128 (2022) - p. 105806 , 2022
Link:
https://doi.org/10.1016/..
?
14
Tolerability and antitumor activity of cemiplimab, a human ..:
Moreno, Victor
;
Garrido, Pilar
;
Papadopoulos, Kyriakos P.
...
Lung Cancer. 155 (2021) - p. 151-155 , 2021
Link:
https://doi.org/10.1016/..
?
15
Integrated analysis of a phase 2 study of cemiplimab in adv..:
Rischin, Danny
;
Khushalani, Nikhil I
;
Schmults, Chrysalyne D
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 8 - p. e002757 , 2021
Link:
https://doi.org/10.1136/..
1-15